Synthesis and Biological Activity Evaluation of New Isatin-Gallate Hybrids as Antioxidant and Anticancer Agents (In Vitro) and In Silico Study as Anticancer Agents and Coronavirus Inhibitors

    June 2024 in “ Pharmacia
    May Mohammed Jawad Al-Mudhafar, Jaafar Suhail Wadi
    TLDR New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.
    The study synthesized and evaluated new isatin-gallate hybrids, finding significant antioxidant and cytotoxic effects against cancer cell lines in vitro. In silico studies indicated potential as anticancer agents and coronavirus inhibitors, particularly through interactions with EGFR and RNA polymerase. The research suggests these hybrids have promising therapeutic potential, warranting further investigation into their mechanisms and applications in cancer and viral treatments.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results